Celltrion Nearly Triples Production Capability For Biosimilars In Anticipation Of Global Launches

SEOUL - South Korea's biosimilar front-runner Celltrion, Inc. will begin production at a new 90,000-liter manufacturing plant Oct. 5 located at its main plant in Incheon City